NEW YORK (GenomeWeb News) — Genesis Research and Development will trade its rights to royalties on the sale of a genomics data querying software package for a stake in start-up bioinformatics company Real Time Genomics.

Auckland, New Zealand-based Genesis said today that it is converting the royalty rights to NetValue's SLIM Search software, which is based on Genesis' Cartesian technology, in exchange for a 10 percent stake in the Real Time Genomics. Genesis' interest will be held by New Zealand holding company Gene Value.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.